Affymax has a total of 213 patents globally, out of which 107 have been granted. Of these 213 patents, 2% patents are active. The United States of America is where Affymax has filed the maximum number of patents, followed by Japan and Europe (EPO). Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Affymax.
Affymax was founded in 2001. Affymax is a development-stage biopharmaceutical company focused on creating novel peptide-based therapies for serious and life-threatening diseases. Its lead product, OMONTYS, is an injectable treatment for anemia associated with chronic kidney disease in adult dialysis patients. OMONTYS is a synthetic, peptide-based erythropoiesis-stimulating agent (ESA) that promotes the production of red blood cells and has been the only ESA in the U.S. approved for once-monthly dosing in this patient population.
Do read about some of the most popular patents of Affymax which have been covered by us in this article and also you can find Affymax patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Affymax patent portfolio.
How many patents does Affymax have?
Affymax has a total of 213 patents globally. These patents belong to 26 unique patent families. Out of 213 patents, 2 patents are active.
How Many Patents did Affymax File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Affymax Applications Filed | Affymax Patents Granted |
| 2017 | – | 1 |
| 2016 | – | 2 |
| 2014 | – | 2 |
| 2013 | 2 | 13 |
| 2012 | 9 | 13 |
| 2011 | 2 | 9 |
| 2010 | 3 | 16 |
| 2009 | 3 | 29 |
| 2008 | 22 | 14 |
| 2007 | 11 | 1 |
| 2006 | 30 | 6 |
| 2005 | 34 | 1 |
How many Affymax patents are Alive/Dead?
Worldwide Patents
How Many Patents did Affymax File in Different Countries?
Countries in which Affymax Filed Patents
| Country | Patents |
| United States of America | 34 |
| Japan | 16 |
| Europe (EPO) | 15 |
| Korea (South) | 8 |
| Israel | 8 |
| Australia | 7 |
| Hong Kong (S.A.R.) | 6 |
| Mexico | 6 |
| New Zealand | 6 |
| China | 6 |
| Norway | 6 |
| India | 5 |
| Germany | 5 |
| Singapore | 5 |
| Eurasia | 5 |
| Brazil | 5 |
| South Africa | 4 |
| Iceland | 4 |
| Italy | 3 |
| Austria | 3 |
| Canada | 3 |
| Africa | 3 |
| Estonia | 2 |
| Spain | 2 |
| Slovenia | 2 |
| Slovakia | 2 |
| Poland | 2 |
| Cyprus | 2 |
| Indonesia | 2 |
| Croatia | 2 |
| Costa Rica | 2 |
| Ukraine | 2 |
| Portugal | 2 |
| Denmark | 2 |
| Viet Nam | 2 |
| Hungary | 2 |
| Albania | 1 |
| Montenegro | 1 |
| Georgia | 1 |
| Taiwan | 1 |
| Serbia | 1 |
| Malaysia | 1 |
| Philippines | 1 |
| Morocco | 1 |
Where are Research Centers of Affymax Patents Located?
10 Best Affymax Patents
US7084245B2 is the most popular patent in the Affymax portfolio. It has received 323 citations so far from companies like Amgen, Jiangsu Hansoh Pharmaceutical, Intrinsic Lifesciences.
Below is the list of 10 most cited patents of Affymax:
| Publication Number | Citation Count |
| US7084245B2 | 323 |
| US20050107297A1 | 283 |
| WO2009002947A2 | 56 |
| US20110282029A1 | 36 |
| CN101553242A | 33 |
| US20090131317A1 | 24 |
| US20080090760A2 | 24 |
| US7109299B1 | 22 |
| WO2007044153A1 | 16 |
| US7528104B2 | 15 |
What are Affymax key innovation segments?
What Technologies are Covered by Affymax?
The chart below distributes patents filed by Affymax in different countries on the basis of the technology protected in patents. It also represents the markets where Affymax thinks it’s important to protect particular technological inventions.
R&D Focus: How has Affymax search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Affymax?
